Drawing for GS EFFEX

USPTO serial 79384105

GS EFFEX

Reviewed by CopyMark Law Group

Reg. 7452422Status 700Registered
Filing date
Status date
Registration date
Jul 23, 2024
Examiner
BRADLEY, EVELYN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GS EFFEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

LAWRENCE J CRAIN

LAWRENCE J CRAIN GREER BURNS & CRAIN LTD200 West MadisonSuite 2100CHICAGO, IL 60606

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for scientific research, pharmaceutical research, clinical research and for industrial purposes namely, genetically modified cells and vectors for production of human, animal and synthetic proteinsACTIVE—
005Biological preparations, namely, genetically modified cells and genetically modified vectors for production of human, animal and synthetic proteins, for medical and clinical use in human and animal therapiesACTIVE—
040Custom manufacturing according to third-party orders and specifications of genetically modified cells and vectors for production of human, animal and synthetic proteins, for clinical and commercial use in scientific research and in pharmaceutical research, as well as for clinical and commercial use in human and animal therapiesACTIVE—
042Medical and scientific research in the field of biotechnology; technical consultancy and project planning in the field of biological research relating to proteins; scientific research and development in the field of protein research for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 17, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 29, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 29, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 8, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 16, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 16, 2025FIMPFINAL DISPOSITION PROCESSED—
Oct 24, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 12, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 12, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 23, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 23, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 7, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 7, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 8, 2024RFNTREFUSAL PROCESSED BY IB—
Mar 30, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 30, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Mar 30, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 30, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 30, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 29, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 28, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 28, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 20, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 20, 2024RFRRREFUSAL PROCESSED BY MPU—
Feb 29, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 28, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2024DOCKASSIGNED TO EXAMINER—
Dec 8, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 4, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 30, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance